Bal Pharma has informed that the trading window for dealing with the securities of the Company on the designated persons and their immediate relatives will be closed from 18 July 2025 and up to 48 hours of the declaration of the unaudited financial results of the Company for the quarter ended 30/06/2025. The date of the Board meeting for declaration of the unaudited financial results will be intimated to the exchange in due course.
The above information is a part of company’s filings submitted to BSE.
